About Abiochem Biotechnology
Abiochem Biotechnology is a company based in Minhang (China) founded in 2013. CRO and CMO services focused on biocatalysis technologies are provided. Abiochem Biotechnology has raised $14.44 million across 3 funding rounds from investors including Temasek, CMB International Capital and Huatai Zijin Investment. Abiochem Biotechnology offers products and services including Enzymes and Synthetic Compounds. Its legal entity in India is εΌζ―θ±ηη©η§ζοΌιε’οΌθ‘δ»½ζιε ¬εΈ (U99999MH1977PLC010754).
Company details
Abiochem Biotechnology was established in 2013 and is based in Minhang, China. Operations are centered in the biotechnology sector, where contract research organization (CRO) and contract manufacturing organization (CMO) services are delivered. Emphasis is placed on biocatalysis technologies to support client needs in research and production. The companys domain, abiochem.com, facilitates these activities across relevant geographic and industrial contexts.
- Headquarters Minhang, China
- Phoneβ’β’β’β’ β’β’β’β’
- Website abiochem.com
- Social LinkedIn
- Legal Name 弈柯莱生物科技（集团）股份有限公司
- Date of Incorporation 10 Aug, 1977
- Jurisdiction Maharashtra, India
- Total Equity Funding$14.44M (USD)
in 3 rounds
- InvestorsTemasek
& 5 more
Associated legal entities of Abiochem Biotechnology
Abiochem Biotechnology operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | View details |
Products & Services of Abiochem Biotechnology
Abiochem Biotechnology offers a comprehensive portfolio of products and services, including Enzymes and Synthetic Compounds.
Enzymes are designed and produced for industrial catalysis and synthetic processes in various sectors.
Synthetic compounds are manufactured for applications in biomedicine and agriculture to support sustainable production.
Funding Insights of Abiochem Biotechnology
Abiochem Biotechnology has successfully raised a total of $14.44M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.44M
- Total Rounds 3
- First Round $14.44M
(Jun 2019)
- Investors Count 6
All 3 funding rounds of Abiochem Biotechnology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2021 | Series C | β | Temasek, CMB International Capital | β | |
| Nov 2020 | Series B | β | Huatai Zijin Investment | ||
| Jun 2019 | $14.44M | Series B | β | Huatai Zijin Investment |
6 investors in total: 6 institutional.
Investors in Abiochem Biotechnology
Abiochem Biotechnology has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Temasek, CMB International Capital and Huatai Zijin Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
An investment platform is provided for diverse sectors and geographies. | 1974 | temasek.com.sg | Singapore, Singapore | |
| beyondfund.com | ||||
Investments are made by Addor Capital in early-stage technology companies. | addorcapital.com | Nanjing, China | ||
Healthcare startups are funded by HLC venture capital firm. | hlc.com.cn | Shanghai, China | ||
| cmbi.com.hk | ||||
Manages diversified investment portfolios across various asset classes. | 1991 | htzjtz.com.cn | Nanjing, China |
Investor details for Abiochem Biotechnology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Abiochem Biotechnology
3 dated milestones of Abiochem Biotechnology across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Abiochem Biotechnology is founded.
- Funding First funding round of $14.4M.
- Funding Latest funding round, Series C,.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Abiochem Biotechnology
Complete news archive for Abiochem Biotechnology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abiochem Biotechnology
Abiochem Biotechnology was founded in 2013 and raised its 1st funding round 6 years after it was founded.
Abiochem Biotechnology is headquartered in Minhang, China. It is registered at Minhang, Shanghai, China.
Abiochem Biotechnology is a funded company, having raised a total of $14.44M across 3 funding rounds to date. The company's 1st funding round was a Series B of $14.44M, raised on Jun 2019.
Abiochem Biotechnology was established in 2013 and is based in Minhang, China. Operations are centered in the biotechnology sector, where contract research organization (CRO) and contract manufacturing organization (CMO) services are delivered. Emphasis is placed on biocatalysis technologies to support client needs in research and production. The companys domain, abiochem.com, facilitates these activities across relevant geographic and industrial contexts.
Abiochem Biotechnology offers Enzymes and Synthetic Compounds.
Abiochem Biotechnology has 6 investors. Key investors include Temasek, CMB International Capital, Huatai Zijin Investment, Binghong Capital, and Addor Capital.
Abiochem Biotechnology operates through ,.